Advanced Oncotherapy

Advanced Oncotherapy is a specialist developer and provider of the next generation of particle therapy systems that makes radiation less toxic for patients. Our aim is to create a bright future in cancer care with our advanced LIGHT technology. Vision: To develop a more affordable proton-based radiotherapy system, using an innovative and clinically more effective technology, and saving more cancer lives. Mission: To facilitate the wider use of radiation with protons for treating all forms of radio-sensitive cancers by commercialising a novel technology, and building on the success and scientific know-how of CERN (Centre Européen pour la Recherche Nucléaire).
Type
Public
HQ
London, GB
Founded
1994
Employees
29 (est)
Advanced Oncotherapy was founded in 1994 and is headquartered in London, GB

Advanced Oncotherapy Locations

London, GB
Syracuse, US
Rolle, CH

Advanced Oncotherapy Metrics

Advanced Oncotherapy Summary

Market capitalization

£27.7 M

Closing share price

£0.49
Advanced Oncotherapy's latest market capitalization is £27.7 M.

Advanced Oncotherapy Financials

Advanced Oncotherapy's revenue was £84.2 K in FY, 2015 which is 20.81% decrease from the previous period.
FY, 2013FY, 2014FY, 2015

Revenue

£68.9 K£106 K£84.2 K

Revenue growth, %

54.4%-20.8%

Cost of sales

£156 K£203 K£110 K

Gross profit

£-87 K£-96.3 K£-25.5 K

Gross profit Margin, %

-126.3%-90.5%-30.3%

Operating expense total

£3.09 M£5.74 M£8.48 M

Advanced Oncotherapy Market Value History

12.87% of current employees of Advanced Oncotherapy are female and 87.13% are male.

Advanced Oncotherapy Online Presence

Advanced Oncotherapy Company Life

You may also be interested in